List of high-quality authors
Hisco: IND application for new indication of innovative drug HSK16149 capsule was accepted].
Haisco announced that it has obtained the "Notice of Acceptance" for the IND application for the new indication of the innovative drug HSK16149 capsule, and this product is intended to be used for ** central nervous system pathic pain.
Cowealth China: Consolidated revenue in 2023 will be 109.9 billion yuan, a year-on-year decrease of 1411%】
Cowealth China announced that the company's consolidated operating income from January to December 2023 was 109.9 billion yuan, a decrease of 14 percent from the consolidated operating income in the same period last year11%。
Qifeng New Materials: Application for issuance to specific objects** approved by the Shenzhen Stock Exchange].
Qifeng New Materials announced that the company's application for issuance to specific objects was approved by the Listing Review Center of the Shenzhen Stock Exchange.
Humanwell Pharmaceutical: Peony licorice granules obtained the drug registration certificate].
Humanwell Pharmaceutical announced that its subsidiary, Kangle Pharmaceutical, obtained the drug registration certificate for peony licorice granules.
Xin Fengming: The subsidiary plans to invest about 20 billion yuan in the construction of differentiated polyester fiber materials and polyester film materials projects
Xinfengming announced that its wholly-owned subsidiary, Zhonghong New Materials, plans to invest in the construction of a project with an annual output of 2.5 million tons of differentiated polyester fiber materials and 100,000 tons of polyester film materials, with a total investment of about 20 billion yuan.